Global Human Insulin Drugs Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

Segmented by Product Type;

Bolus or Fast-acting Insulins - NovoRapid/Novolog (Insulin aspart), Humalog (Insulin lispro), Apidra (Insulin glulisine), FIASP (Insulin aspart) and Admelog (Insulin lispro), Basal or Long-acting Insulins - Lantus (Insulin glargine), Levemir (Insulin detemir), Toujeo (Insulin glargine), Tresiba (Insulin degludec) and Basaglar (Insulin glargine), Traditional Human Insulins - Novolin/Actrapid/Insulatard, Humulin and Insuman, Combination Insulins - NovoMix (Biphasic Insulin aspart), Ryzodeg (Insulin degludec/Insulin aspart), Xultophy (Insulin degludec/Liraglutide) and Soliqua/Suliqua (Insulin glargine/Lixisenatide), Biosimilar Insulins - Insulin Glargine Biosimilars and Human Insulin Biosimilars.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2018 - 2028).
Report ID: Rn594332659 Published Date: April, 2022 Updated Date: May, 2022

Introduction

Global Human Insulin Drugs Market (USD Million), 2018 - 2028

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2018 - 2028
2018 98.1
2019 104.7
2020 105.4
2021 111.9
2022 116.8
2023 133.5
2024 153.8
2025 163.5
2026 172.7
2027 173.5
2028 190.8

In the year 2021, the Global Human Insulin Drugs Market was valued at USD 22,964.61 million. The size of this market is expected to increase to USD 32,098.70 million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of 4.9%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Region
    3. Market Opportunity Map
  4. Global Human Insulin Drugs Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
      2. Restraints
      3. Opportunities
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Human Insulin Drugs Market, By Product Type, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Bolus or Fast-acting Insulins
          1. Introduction
          2. Market Share Analysis, 2022 and 2028 (%)
          3. Y-o-Y Growth Analysis, 2019 - 2028
          4. Segment Trends
            1. NovoRapid/Novolog (Insulin aspart)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            2. Humalog (Insulin lispro)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            3. Apidra (Insulin glulisine)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            4. FIASP (Insulin aspart)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            5. Admelog (Insulin lispro)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Basal or Long-acting Insulins
          1. Introduction
          2. Market Share Analysis, 2022 and 2028 (%)
          3. Y-o-Y Growth Analysis, 2019 - 2028
          4. Segment Trends
            1. Lantus (Insulin glargine)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            2. Levemir (Insulin detemir)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            3. Toujeo (Insulin glargine)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            4. Tresiba (Insulin degludec)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            5. Basaglar (Insulin glargine)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        3. Traditional Human Insulins
          1. Introduction
          2. Market Share Analysis, 2022 and 2028 (%)
          3. Y-o-Y Growth Analysis, 2019 - 2028
          4. Segment Trends
            1. Novolin/Actrapid/Insulatard
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            2. Humulin
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            3. Insuman
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        4. Combination Insulins
          1. Introduction
          2. Market Share Analysis, 2022 and 2028 (%)
          3. Y-o-Y Growth Analysis, 2019 - 2028
          4. Segment Trends
            1. NovoMix (Biphasic Insulin aspart)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            2. Ryzodeg (Insulin degludec/Insulin aspart)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            3. Xultophy (Insulin degludec/Liraglutide)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            4. Soliqua/Suliqua (Insulin glargine/Lixisenatide)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        5. Biosimilar Insulins
          1. Introduction
          2. Market Share Analysis, 2022 and 2028 (%)
          3. Y-o-Y Growth Analysis, 2019 - 2028
          4. Segment Trends
            1. Insulin Glargine Biosimilars
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
            2. Human Insulin Biosimilars
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    2. Global Human Insulin Drugs Market, By Geography, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
        4. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
        5. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018 - 2028 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. Novo Nordisk A/S
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Eli Lilly and Company
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Sanofi S.A.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. Biocon Limited
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Pfizer Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Medical Devices Human Liver Models
Global Human Liver Models Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Human Liver Models Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Human Papillomavirus Vaccine
Global Human Papillomavirus Vaccine Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Human Papillomavirus Vaccine Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Biotechnology Human Placental Protein
Global Human Placental Protein Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Human Placental Protein Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Human Rotavirus Vaccine
Global Human Rotavirus Vaccine Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Human Rotavirus Vaccine Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...